首页 > 最新文献

Acta medica academica最新文献

英文 中文
Lyssa: Goddess, Drug, Illness and Shield in Hellenic Antiquity. Lyssa:希腊古代的女神、药物、疾病和盾牌。
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.5644/ama2006-124.444
Gregory Tsoucalas

The aim of this historical review is to present the beliefs of the ancient Greeks related to lyssa and how the mythology surrounding this disease was created. In Greek antiquity Lyssa was a secondary goddess, a personification of a zoonotic disease which could be transmitted after an animal bite. Also named hydrophobia, the illness lyssa presented with an acute loss of mental stability, offensive frenzy and madness, and fear of water in the patient, who was seen to be possessed by a daemon as a divine punishment. In the Trojan War, lyssa was seen as a drug to Greek warriors, to demonstrate unreal power during battle. Homer was the first to refer to the hound of Orion, who was the greatest ancient Greek hunter. The hound, named Sirius, as a carrier of lyssa, was used as a bio-weapon to inflict death among the Trojans. Soranus of Ephesus and Galen gave descriptions of the disease, and proposed a sponge soaked with various herbal drugs as a therapeutic measure. The Greco-Roman physician Caelius Aurelianus noted that ancient Greeks knew about lyssa, and was the first to suggest that this was a neuro-disease. Lyssa was a figure in Greek Tragedy, depicted as a young female with a dog-like crown, related to Erinyes and Maniae. CONCLUSION: Lyssa was noted as a disease in Hellenic literature more than 2500 years ago. It was used as a bio-weapon to inflict madness. This vignette reveals Lyssa within a historical framework for the reader to understand the disease's origins.

本历史回顾旨在介绍古希腊人与莱萨有关的信仰,以及围绕这种疾病的神话是如何产生的。在古希腊,Lyssa 是一个次级女神,是一种人畜共患病的化身,这种疾病可在被动物咬伤后传播。莱萨病也被称为恐水症,表现为患者精神急剧失稳、攻击性狂热和疯狂,以及对水的恐惧,患者被视为被大恶魔附身,受到神的惩罚。在特洛伊战争中,lyssa 被视为希腊战士的一种药物,可以在战斗中展现虚幻的力量。荷马是第一个提到猎户座猎犬的人,他是古希腊最伟大的猎手。这条名为天狼星的猎犬是莱萨的载体,被用作生化武器,在特洛伊人中造成死亡。以弗所的索拉努斯和盖伦描述了这种疾病,并提出用海绵浸泡各种草药作为治疗措施。古希腊罗马医生凯利乌斯-奥雷利安努斯(Caelius Aurelianus)指出古希腊人知道 lyssa,并且是第一个提出这是一种神经疾病的人。Lyssa 是希腊悲剧中的一个人物,被描绘成一个头戴狗冠的年轻女性,与 Erinyes 和 Maniae 有关。结论:在 2500 多年前的希腊文学作品中,Lyssa 就已被视为一种疾病。它被用作一种生物武器,使人疯狂。本小节在历史框架内揭示了 Lyssa,以便读者了解这种疾病的起源。
{"title":"Lyssa: Goddess, Drug, Illness and Shield in Hellenic Antiquity.","authors":"Gregory Tsoucalas","doi":"10.5644/ama2006-124.444","DOIUrl":"10.5644/ama2006-124.444","url":null,"abstract":"<p><p>The aim of this historical review is to present the beliefs of the ancient Greeks related to lyssa and how the mythology surrounding this disease was created. In Greek antiquity Lyssa was a secondary goddess, a personification of a zoonotic disease which could be transmitted after an animal bite. Also named hydrophobia, the illness lyssa presented with an acute loss of mental stability, offensive frenzy and madness, and fear of water in the patient, who was seen to be possessed by a daemon as a divine punishment. In the Trojan War, lyssa was seen as a drug to Greek warriors, to demonstrate unreal power during battle. Homer was the first to refer to the hound of Orion, who was the greatest ancient Greek hunter. The hound, named Sirius, as a carrier of lyssa, was used as a bio-weapon to inflict death among the Trojans. Soranus of Ephesus and Galen gave descriptions of the disease, and proposed a sponge soaked with various herbal drugs as a therapeutic measure. The Greco-Roman physician Caelius Aurelianus noted that ancient Greeks knew about lyssa, and was the first to suggest that this was a neuro-disease. Lyssa was a figure in Greek Tragedy, depicted as a young female with a dog-like crown, related to Erinyes and Maniae. CONCLUSION: Lyssa was noted as a disease in Hellenic literature more than 2500 years ago. It was used as a bio-weapon to inflict madness. This vignette reveals Lyssa within a historical framework for the reader to understand the disease's origins.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":" ","pages":"233-236"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142009606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selenium and Triple Negative Breast Cancer. 硒与三阴性乳腺癌的关系
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.5644/ama2006-124.450
Despoina Sidira, Angeliki Siafaka, Dimosthenis Chrysikos, Georgios Papadopoulos, Epameinondas Stratopoulos, Dimitrios Filippou

Background: The deadliest, most dangerous subtype of breast cancer is triple-negative, which lacks treatment targets and accounts for 30% of all breast cancer-related deaths worldwide. TNBC is characterized by the expression of no estrogen, progesterone, or human epidermal growth factor 2 receptors. This suggests that new treatment modalities with fewer adverse effects are required.

Objective: The aim of the present study was to investigate the therapeutic potential of selenium compounds as an adjuvant therapy for Triple Negative Breast Cancer (TNBC), either on their own or in conjunction with nutritional supplements and chemotherapy medications.

Methods: Using the keywords "selenium" and "triple negative breast cancer", a thorough search was conducted in the PubMed database, yielding 23 articles. The following factors were taken into consideration for inclusion: studies using TNBC cell culture lines or in vivo tumors/specimens; full-text articles from the PubMed database; studies published in the English language; experiments with statistically significant results; and selenium used alone or in combination with other antioxidants or chemotherapy. This led to the evaluation of 13 articles in this review.

Results: The results show that selenium therapy increased the anti-cancer drug's effects and produced tumor cytotoxicity, while reducing the cellular features of the cancer (hyperproliferation, growth, and metastasis).

Discussion: This study evaluated the various selenium compounds tested, the cell lines and model organisms used, the assays performed, and the cellular pathways affected.

Conclusion: Examining the possible benefits of selenium in TNBC treatment highlights the need for more studies to confirm selenium compounds as viable co-therapeutic agents.

背景:最致命、最危险的乳腺癌亚型是三阴性,缺乏治疗目标,占全世界所有乳腺癌相关死亡的30%。TNBC的特点是不表达雌激素、黄体酮或人表皮生长因子2受体。这表明需要不良反应更少的新治疗方式。目的:本研究的目的是研究硒化合物作为三阴性乳腺癌(TNBC)辅助治疗的治疗潜力,无论是单独使用还是与营养补充剂和化疗药物联合使用。方法:以“硒”和“三阴性乳腺癌”为关键词,在PubMed数据库中进行全面检索,得到23篇文章。纳入时考虑了以下因素:使用TNBC细胞培养系或体内肿瘤/标本的研究;PubMed数据库中的全文文章;用英语发表的研究;结果有统计学意义的实验;硒单独使用或与其他抗氧化剂或化疗联合使用。因此,本综述对13篇文章进行了评价。结果:结果表明,硒治疗增加了抗癌药物的作用,产生了肿瘤细胞毒性,同时降低了肿瘤的细胞特征(过度增殖、生长和转移)。讨论:本研究评估了所测试的各种硒化合物,所使用的细胞系和模式生物,所进行的分析以及所影响的细胞途径。结论:考察硒在TNBC治疗中可能的益处,强调需要更多的研究来证实硒化合物作为可行的联合治疗剂。
{"title":"Selenium and Triple Negative Breast Cancer.","authors":"Despoina Sidira, Angeliki Siafaka, Dimosthenis Chrysikos, Georgios Papadopoulos, Epameinondas Stratopoulos, Dimitrios Filippou","doi":"10.5644/ama2006-124.450","DOIUrl":"10.5644/ama2006-124.450","url":null,"abstract":"<p><strong>Background: </strong>The deadliest, most dangerous subtype of breast cancer is triple-negative, which lacks treatment targets and accounts for 30% of all breast cancer-related deaths worldwide. TNBC is characterized by the expression of no estrogen, progesterone, or human epidermal growth factor 2 receptors. This suggests that new treatment modalities with fewer adverse effects are required.</p><p><strong>Objective: </strong>The aim of the present study was to investigate the therapeutic potential of selenium compounds as an adjuvant therapy for Triple Negative Breast Cancer (TNBC), either on their own or in conjunction with nutritional supplements and chemotherapy medications.</p><p><strong>Methods: </strong>Using the keywords \"selenium\" and \"triple negative breast cancer\", a thorough search was conducted in the PubMed database, yielding 23 articles. The following factors were taken into consideration for inclusion: studies using TNBC cell culture lines or in vivo tumors/specimens; full-text articles from the PubMed database; studies published in the English language; experiments with statistically significant results; and selenium used alone or in combination with other antioxidants or chemotherapy. This led to the evaluation of 13 articles in this review.</p><p><strong>Results: </strong>The results show that selenium therapy increased the anti-cancer drug's effects and produced tumor cytotoxicity, while reducing the cellular features of the cancer (hyperproliferation, growth, and metastasis).</p><p><strong>Discussion: </strong>This study evaluated the various selenium compounds tested, the cell lines and model organisms used, the assays performed, and the cellular pathways affected.</p><p><strong>Conclusion: </strong>Examining the possible benefits of selenium in TNBC treatment highlights the need for more studies to confirm selenium compounds as viable co-therapeutic agents.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"53 2","pages":"155-164"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142787247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Academician Milivoje Sarvan: The Founder of Modern Paediatrics in Bosnia and Herzegovina. Milivoje Sarvan院士:波斯尼亚和黑塞哥维那现代儿科的创始人。
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.5644/ama2006-124.457
Husref Tahirović, Jelena Jovanović Simić
<p><p>The aim of the article is to present to the medical, and then to the general public, the person and work of Milivoje Sarvan (1896-1978)-one of the pioneers of social paediatrics in Serbia and one of the most prominent paediatricians, scientists and organizers of health services in Bosnia and Herzegovina in the second half of the 20th century. Milivoje Sarvan was born in 1896 in Požega, in the Kingdom of Serbia. He completed his medical studies in Lyon (France) in 1921. Upon his return to Serbia, he was a county physician in Aleksinac for three years and, shortly after the establishment of the University Children's Hospital in Belgrade in 1924, he was among the first assistants employed there. Out of the total of 23 years of professional work in Serbia, for 19 years he was an assistant and assistant professor at the Faculty of Medicine in Belgrade. At the end of 1946, at the initiative of the Ministry of Public Health of the People's Republic of Bosnia and Herzegovina, Dr. Milivoje Sarvan was appointed full professor and head of the Department of Paediatrics at the newly established Faculty of Medicine in Sarajevo. At the same time, he was elected head of the Paediatric Clinic in Sarajevo when it was established, and he would later manage it from 1947 until his retirement in 1967. Already at the beginning, Prof. Sarvan developed the activities of the Clinic in several directions: he created the conditions for clinical, teaching and scientific research work. He took care of the education of future paediatricians and child care workers, organized courses in social paediatrics for general practitioners and professional training for paediatricians in the country and abroad. The next period of his activities was marked by the intensive development of the Clinic in all areas of its work. He published more than 120 professional and scientific papers in national and foreign medical journals, and several health education books on mother and child care that have been published in several editions, with large print runs. He was the dean of the Faculty of Medicine and vice-rector of the University of Sarajevo, founder of the Paediatric Section of the Society of Physicians of Bosnia and Herzegovina, lifetime president of the Association of Paediatricians of Yugoslavia, a member of the Scientific Society of Bosnia and Herzegovina from 1955 and the Academy of Sciences and Arts of Bosnia and Herzegovina from its foundation in 1966. He was honoured with high level social awards and recognitions, including the highest state award of the Socialist Federative Republic of Yugoslavia-the AVNOJ award. After his retirement (1967), he lived in Belgrade, where he died in 1978. CONCLUSION: Bearing all of this in mind, there is no doubt that Dr. Milivoje Sarvan is one of the significant figures in the field of professional, scientific and organizational work in the field of children's health care in the former Yugoslavia, leaving a significant and indelible mark in the
这篇文章的目的是向医学界,然后向公众介绍米利沃耶·萨尔万(1896-1978)的个人和工作,他是塞尔维亚社会儿科的先驱之一,也是20世纪下半叶波斯尼亚和黑塞哥维那最杰出的儿科医生、科学家和卫生服务组织者之一。米利沃耶·萨尔万1896年出生于塞尔维亚王国Požega。他于1921年在法国里昂完成了他的医学研究。回到塞尔维亚后,他在阿列克谢纳茨当了三年县里的医生,1924年贝尔格莱德大学儿童医院成立后不久,他是那里雇用的第一批助理医生之一。在塞尔维亚总共23年的专业工作中,他有19年是贝尔格莱德医学院的助理和助理教授。1946年底,在波斯尼亚-黑塞哥维那人民共和国公共卫生部的倡议下,米利沃耶·萨尔万博士被任命为萨拉热窝新成立的医学院的正教授和儿科系主任。与此同时,他在萨拉热窝儿科诊所成立时被选为主任,他后来从1947年开始管理该诊所,直到1967年退休。早在一开始,Sarvan教授就在几个方面发展了诊所的活动:他为临床、教学和科研工作创造了条件。他负责未来儿科医生和儿童保育工作者的教育,为全科医生组织社会儿科课程,并在国内外为儿科医生组织专业培训。他活动的下一个时期的特点是诊所在其所有工作领域的密集发展。在国内外医学期刊上发表专业、科学论文120余篇,出版多本妇幼保健健康教育书籍,印量大。​他被授予高级别的社会奖项和认可,包括南斯拉夫社会主义联邦共和国的最高国家奖- AVNOJ奖。1967年退休后,他住在贝尔格莱德,并于1978年去世。结论:考虑到这一切,毫无疑问,米利沃耶·萨尔万博士是前南斯拉夫儿童保健领域的专业、科学和组织工作领域的重要人物之一,在塞尔维亚和波斯尼亚-黑塞哥维那目前的国家留下了重要和不可磨灭的印记。
{"title":"Academician Milivoje Sarvan: The Founder of Modern Paediatrics in Bosnia and Herzegovina.","authors":"Husref Tahirović, Jelena Jovanović Simić","doi":"10.5644/ama2006-124.457","DOIUrl":"10.5644/ama2006-124.457","url":null,"abstract":"&lt;p&gt;&lt;p&gt;The aim of the article is to present to the medical, and then to the general public, the person and work of Milivoje Sarvan (1896-1978)-one of the pioneers of social paediatrics in Serbia and one of the most prominent paediatricians, scientists and organizers of health services in Bosnia and Herzegovina in the second half of the 20th century. Milivoje Sarvan was born in 1896 in Požega, in the Kingdom of Serbia. He completed his medical studies in Lyon (France) in 1921. Upon his return to Serbia, he was a county physician in Aleksinac for three years and, shortly after the establishment of the University Children's Hospital in Belgrade in 1924, he was among the first assistants employed there. Out of the total of 23 years of professional work in Serbia, for 19 years he was an assistant and assistant professor at the Faculty of Medicine in Belgrade. At the end of 1946, at the initiative of the Ministry of Public Health of the People's Republic of Bosnia and Herzegovina, Dr. Milivoje Sarvan was appointed full professor and head of the Department of Paediatrics at the newly established Faculty of Medicine in Sarajevo. At the same time, he was elected head of the Paediatric Clinic in Sarajevo when it was established, and he would later manage it from 1947 until his retirement in 1967. Already at the beginning, Prof. Sarvan developed the activities of the Clinic in several directions: he created the conditions for clinical, teaching and scientific research work. He took care of the education of future paediatricians and child care workers, organized courses in social paediatrics for general practitioners and professional training for paediatricians in the country and abroad. The next period of his activities was marked by the intensive development of the Clinic in all areas of its work. He published more than 120 professional and scientific papers in national and foreign medical journals, and several health education books on mother and child care that have been published in several editions, with large print runs. He was the dean of the Faculty of Medicine and vice-rector of the University of Sarajevo, founder of the Paediatric Section of the Society of Physicians of Bosnia and Herzegovina, lifetime president of the Association of Paediatricians of Yugoslavia, a member of the Scientific Society of Bosnia and Herzegovina from 1955 and the Academy of Sciences and Arts of Bosnia and Herzegovina from its foundation in 1966. He was honoured with high level social awards and recognitions, including the highest state award of the Socialist Federative Republic of Yugoslavia-the AVNOJ award. After his retirement (1967), he lived in Belgrade, where he died in 1978. CONCLUSION: Bearing all of this in mind, there is no doubt that Dr. Milivoje Sarvan is one of the significant figures in the field of professional, scientific and organizational work in the field of children's health care in the former Yugoslavia, leaving a significant and indelible mark in the","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"53 2","pages":"209-232"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142787227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Online Workshops Versus Live Medical Education on Self-Medication Literacy for Middle School Students. What Is the Best Pedagogic Method? 在线研讨会与现场医学教育对中学生自我药疗素养的影响。什么是最好的教学方法?
Q3 Medicine Pub Date : 2024-08-01 DOI: 10.5644/ama2006-124.449
Ghita Dubory, Victor Housset, Roxanne Liard, Claire Bastard, Marine Joulin, Angelo V Vasiliadis, Arnaud Dubory, Vasileios Giovanoulis

Objective: This study aimed to determine which pedagogic method, online workshops or live medical education, was the better way to teach about self-medication for middle school students.

Methods: The following groups were formed: group O (students receiving online education), group L (students participating in live medical education animated by a medical practitioner and a science teacher) and group C (students without any medical learning). To compare them, the students answered three multiple choice questions before and after the educational intervention. The students in group L were evaluated immediately after the live medical training and group O immediately after the online workshops (t1). Group C was only evaluated at t0.

Results: Group C N=195), group L (N=219) and group O (N=200, but 101 students who participated in the online workshops students dropped out before the end) were equivalent in terms of gender, but their ages and school grades were statistically different (P<0.001). A post-hoc test revealed that students in group O were older and in a higher grade than those in the other two groups (P<0.001) but the mean ages and school grades were equivalent in group L and group C. At t0, the results obtained were equivalent in the 3 groups. At t1, school students obtained better results in both groups (P<0.001) but these same results were significantly better in group L than those obtained in group O (P<0.001). Age, gender, school grade and school level had no effect on the students' results.

Conclusion: The study's findings suggest that live medical education is a superior approach for imparting self-medication knowledge to middle school students.

目的:探讨在线研讨会和现场医学教育在中学生自我药疗教学中的效果。方法:分为三组:O组(接受在线教育的学生)、L组(由一名医生和一名科学教师进行现场医学教育的学生)和C组(未接受任何医学学习的学生)。为了进行比较,学生们在教育干预前后分别回答了三个选择题。L组学生在现场医学培训后立即进行评估,O组学生在在线研讨会后立即进行评估(t1)。C组仅在0时进行评估。结果:C组(N= 195)、L组(N=219)、O组(N=200),其中参加在线研修班的101名学生(中途退学)性别相当,但年龄和学业成绩差异有统计学意义(p)结论:现场医学教育是中学生自我药疗知识传授的一种较好的方式。
{"title":"Online Workshops Versus Live Medical Education on Self-Medication Literacy for Middle School Students. What Is the Best Pedagogic Method?","authors":"Ghita Dubory, Victor Housset, Roxanne Liard, Claire Bastard, Marine Joulin, Angelo V Vasiliadis, Arnaud Dubory, Vasileios Giovanoulis","doi":"10.5644/ama2006-124.449","DOIUrl":"10.5644/ama2006-124.449","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to determine which pedagogic method, online workshops or live medical education, was the better way to teach about self-medication for middle school students.</p><p><strong>Methods: </strong>The following groups were formed: group O (students receiving online education), group L (students participating in live medical education animated by a medical practitioner and a science teacher) and group C (students without any medical learning). To compare them, the students answered three multiple choice questions before and after the educational intervention. The students in group L were evaluated immediately after the live medical training and group O immediately after the online workshops (t1). Group C was only evaluated at t0.</p><p><strong>Results: </strong>Group C N=195), group L (N=219) and group O (N=200, but 101 students who participated in the online workshops students dropped out before the end) were equivalent in terms of gender, but their ages and school grades were statistically different (P<0.001). A post-hoc test revealed that students in group O were older and in a higher grade than those in the other two groups (P<0.001) but the mean ages and school grades were equivalent in group L and group C. At t0, the results obtained were equivalent in the 3 groups. At t1, school students obtained better results in both groups (P<0.001) but these same results were significantly better in group L than those obtained in group O (P<0.001). Age, gender, school grade and school level had no effect on the students' results.</p><p><strong>Conclusion: </strong>The study's findings suggest that live medical education is a superior approach for imparting self-medication knowledge to middle school students.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"53 2","pages":"146-154"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142787253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Pressure Recording Analytical Method in Patients Undergoing Endovascular Repair for Abdominal Aortic Aneurysm: The Impact on Clinical Decisions for the Appropriate Postoperative Setting and Cost-effective Analysis 在接受腹主动脉瘤血管内修复术的患者中使用压力记录分析方法:对术后适当设置的临床决策的影响及成本效益分析
Q3 Medicine Pub Date : 2024-06-12 DOI: 10.5644/ama2006-124.442
E. Giacomelli, W. Dorigo, S. Romano, Andrea Casini, C. Giglioli, Chiara Papini, A. Fargion, N. Marchionni, C. Pratesi, R. Pulli, E. Cecchi
Objective. To analyze the use of the Pressure Recording Analytical Method (PRAM), an hemodynamic monitoring system, in evaluating intraoperative and postoperative hemodynamic instability in patients undergoing endovascular repair for abdominal aortic aneurysm, and to evaluate if the decision to refer patients to a ordinary ward or to a Cardiac Step-Down Unit (CSDU) after the intervention on the basis of intraoperative hemodynamic monitoring could be more cost-effective. Materials and Methods. After preoperative clinical evaluation, 44 patients were divided in this non-randomised study into two groups accord- ing to their postoperative destination: Group 1-ward (N=22) and Group 2-CSDU (N=22). All patients underwent monitoring with PRAM during the intervention and in the 24 postoperative hours, measuring several indices of myocardial contractility and other hemodynamic variables. Results. According to the variability of two parameters, Stroke Volume Variation and Pulse Pressure Variation, patients were classified as stable or unstable. Unstable patients showed a significant alteration in several hemodynamic indices, in comparison to stable ones. According to the intraoperative monitoring, eight high risk patients could have been sent to an ordinary ward due to their stability, with a reduction in the improper use of CSDU and, consequently, in costs. Conclusions. Hemodynamic monitoring with PRAM can be useful in these patients, both for intraoperative management and for the choice of the more appropriate postoperative setting, possibly reducing the improper use of CSDU for hemodynami- cally stable patients who are judged to be at high risk preoperatively, and re-evaluating low surgical risk patients with an unstable intraoperative pattern, with a possible reduction in costs.
目的分析血流动力学监测系统压力记录分析法(PRAM)在评估腹主动脉瘤血管内修复术患者术中和术后血流动力学不稳定性中的应用,并评估根据术中血流动力学监测结果决定将患者转入普通病房还是介入治疗后转入心脏降压病房(CSDU)是否更具成本效益。材料与方法。在这项非随机研究中,44 名患者经过术前临床评估后,根据术后去向分为两组:第一组-病房(22 人)和第二组-CSDU(22 人)。所有患者在介入治疗期间和术后 24 小时内都接受了 PRAM 监测,测量心肌收缩力的多个指标和其他血液动力学变量。 结果显示根据两个参数的变化,即卒中容量变化和脉压变化,患者被分为稳定型和不稳定型。与稳定型患者相比,不稳定型患者的几项血流动力学指标出现了显著变化。根据术中监测结果,有八名高危患者因病情稳定而被送往普通病房,从而减少了CSDU的不当使用,降低了费用。结论使用 PRAM 进行血流动力学监测对这些患者非常有用,既有助于术中管理,也有助于选择更合适的术后环境,可能会减少术前判断为高风险的血流动力学稳定患者对 CSDU 的不当使用,并对术中模式不稳定的低手术风险患者进行重新评估,从而可能减少费用。
{"title":"The Use of Pressure Recording Analytical Method in Patients Undergoing Endovascular Repair for Abdominal Aortic Aneurysm: The Impact on Clinical Decisions for the Appropriate Postoperative Setting and Cost-effective Analysis","authors":"E. Giacomelli, W. Dorigo, S. Romano, Andrea Casini, C. Giglioli, Chiara Papini, A. Fargion, N. Marchionni, C. Pratesi, R. Pulli, E. Cecchi","doi":"10.5644/ama2006-124.442","DOIUrl":"https://doi.org/10.5644/ama2006-124.442","url":null,"abstract":"Objective. To analyze the use of the Pressure Recording Analytical Method (PRAM), an hemodynamic monitoring system, in evaluating intraoperative and postoperative hemodynamic instability in patients undergoing endovascular repair for abdominal aortic aneurysm, and to evaluate if the decision to refer patients to a ordinary ward or to a Cardiac Step-Down Unit (CSDU) after the intervention on the basis of intraoperative hemodynamic monitoring could be more cost-effective. \u0000Materials and Methods. After preoperative clinical evaluation, 44 patients were divided in this non-randomised study into two groups accord- ing to their postoperative destination: Group 1-ward (N=22) and Group 2-CSDU (N=22). All patients underwent monitoring with PRAM during the intervention and in the 24 postoperative hours, measuring several indices of myocardial contractility and other hemodynamic variables. \u0000 Results. According to the variability of two parameters, Stroke Volume Variation and Pulse Pressure Variation, patients were classified as stable or unstable. Unstable patients showed a significant alteration in several hemodynamic indices, in comparison to stable ones. According to the intraoperative monitoring, eight high risk patients could have been sent to an ordinary ward due to their stability, with a reduction in the improper use of CSDU and, consequently, in costs. \u0000Conclusions. Hemodynamic monitoring with PRAM can be useful in these patients, both for intraoperative management and for the choice of the more appropriate postoperative setting, possibly reducing the improper use of CSDU for hemodynami- cally stable patients who are judged to be at high risk preoperatively, and re-evaluating low surgical risk patients with an unstable intraoperative pattern, with a possible reduction in costs.","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"77 19","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141352936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Genesis of Multidisciplinary Health Professionals Teams for Pain Management. A History from the Hellenic Antiquity to Modern Palliative Medicine 多学科医护人员疼痛管理团队的起源。从希腊古代到现代姑息医学的发展史
Q3 Medicine Pub Date : 2024-05-14 DOI: 10.5644/ama2006-124.439
Heleni Karassava, Loukas Agorgianitis, Evaggelos Mavrommatis
No abstract available.
无摘要。
{"title":"The Genesis of Multidisciplinary Health Professionals Teams for Pain Management. A History from the Hellenic Antiquity to Modern Palliative Medicine","authors":"Heleni Karassava, Loukas Agorgianitis, Evaggelos Mavrommatis","doi":"10.5644/ama2006-124.439","DOIUrl":"https://doi.org/10.5644/ama2006-124.439","url":null,"abstract":"No abstract available.","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"24 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140980347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late Adverse Effects after Treatment for Childhood Acute Leukemia 儿童急性白血病治疗后的晚期不良反应
Q3 Medicine Pub Date : 2024-04-15 DOI: 10.5644/ama2006-124.438
Jelena Roganovic, Riccardo Haupt, E. Bárdi, L. Hjorth, Gisela Michel, Vesna Pavasovic, Katrin Scheinemann, H. V. D. van der Pal, L. Zadravec Zaletel, Ana E. Amariutei, Roderick Skinner, PanCare Board
The aim of this review is to raise awareness and knowledge among healthcare professionals and policymakers about late adverse effects in survivors of childhood leukemia. With contemporary treatment, over 90% of children with acute lymphoblastic leukemia (ALL) and over 60% with acute myeloid leukemia (AML) are cured. Large cohort studies demonstrate that 20% of ALL and most AML survivors have at least one chronic health condition by 20-25 years after diagnosis. These are life-changing or threatening in some survivors and contribute to increased premature mortality. We describe the frequency, causes, clinical features, and natural history of the most frequent and severe late adverse effects in childhood leukemia survivors, including subsequent malignant neoplasms, metabolic toxicity, gonadotoxicity and impaired fertility, endocrinopathy and growth disturbances, bone toxicity, central and peripheral neurotoxicity, cardiotoxicity, psychosocial late effects, accelerated ageing and late mortality. The wide range of late effects in survivors of haemopoietic stem cell transplant is highlighted. Recent developments informing the approach to long-term survivorship care are discussed, including electronic personalized patient-specific treatment summaries and care plans such as the Survivor Passport (SurPass), surveillance guidelines and models of care. The importance of ongoing vigilance is stressed given the increasing use of novel targeted drugs with limited experience of long-term outcomes. Conclusion. It is vital to raise awareness of the existence and severity of late effects of childhood leukemia therapy among parents, patients, health professionals, and policymakers. Structured long-term surveillance recommendations are necessary to standardize follow-up care.
本综述旨在提高医护人员和决策者对儿童白血病幸存者晚期不良反应的认识和了解。通过现代治疗方法,90% 以上的急性淋巴细胞白血病(ALL)患儿和 60% 以上的急性髓细胞白血病(AML)患儿可以治愈。大型队列研究表明,20% 的急性淋巴细胞白血病(ALL)和大多数急性髓细胞白血病(AML)幸存者在确诊后 20-25 年间至少患有一种慢性疾病。这些病症改变了一些幸存者的生活或对其构成威胁,并导致过早死亡率上升。我们描述了儿童白血病幸存者最常见和最严重的晚期不良反应的频率、原因、临床特征和自然史,包括后续恶性肿瘤、代谢毒性、性腺毒性和生育能力受损、内分泌病变和生长障碍、骨毒性、中枢和外周神经毒性、心脏毒性、心理社会晚期反应、加速衰老和晚期死亡率。重点介绍了造血干细胞移植幸存者的各种晚期效应。讨论了长期幸存者护理方法的最新进展,包括电子个性化患者治疗摘要和护理计划(如幸存者护照(SurPass))、监测指南和护理模式。鉴于新型靶向药物的使用越来越多,但长期疗效经验有限,因此强调了持续警惕的重要性。结论。提高家长、患者、医疗专业人员和政策制定者对儿童白血病治疗后期效应的存在和严重性的认识至关重要。有必要提出结构化的长期监测建议,以规范后续治疗。
{"title":"Late Adverse Effects after Treatment for Childhood Acute Leukemia","authors":"Jelena Roganovic, Riccardo Haupt, E. Bárdi, L. Hjorth, Gisela Michel, Vesna Pavasovic, Katrin Scheinemann, H. V. D. van der Pal, L. Zadravec Zaletel, Ana E. Amariutei, Roderick Skinner, PanCare Board","doi":"10.5644/ama2006-124.438","DOIUrl":"https://doi.org/10.5644/ama2006-124.438","url":null,"abstract":"The aim of this review is to raise awareness and knowledge among healthcare professionals and policymakers about late adverse effects in survivors of childhood leukemia. With contemporary treatment, over 90% of children with acute lymphoblastic leukemia (ALL) and over 60% with acute myeloid leukemia (AML) are cured. Large cohort studies demonstrate that 20% of ALL and most AML survivors have at least one chronic health condition by 20-25 years after diagnosis. These are life-changing or threatening in some survivors and contribute to increased premature mortality. We describe the frequency, causes, clinical features, and natural history of the most frequent and severe late adverse effects in childhood leukemia survivors, including subsequent malignant neoplasms, metabolic toxicity, gonadotoxicity and impaired fertility, endocrinopathy and growth disturbances, bone toxicity, central and peripheral neurotoxicity, cardiotoxicity, psychosocial late effects, accelerated ageing and late mortality. The wide range of late effects in survivors of haemopoietic stem cell transplant is highlighted. Recent developments informing the approach to long-term survivorship care are discussed, including electronic personalized patient-specific treatment summaries and care plans such as the Survivor Passport (SurPass), surveillance guidelines and models of care. The importance of ongoing vigilance is stressed given the increasing use of novel targeted drugs with limited experience of long-term outcomes. \u0000Conclusion. It is vital to raise awareness of the existence and severity of late effects of childhood leukemia therapy among parents, patients, health professionals, and policymakers. Structured long-term surveillance recommendations are necessary to standardize follow-up care.","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"289 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140703933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difficulties in Accessing the List and Full Text of the Defended PhD Theses from Medical Schools: a Retrospective Case Study from Croatia. 获取医学院已答辩博士论文清单和全文的困难:克罗地亚的回顾性案例研究》(Difficulties in Accessing the List and Full Text of the Defended PhD Theses from Medical Schools: a Retrospective Case Study from Croatia)。
Q3 Medicine Pub Date : 2024-04-09 DOI: 10.5644/ama2006-124.437
Livia Puljak, Matea Tolić, Marko Sablić, Vlatko Silobrčić, Marija Heffer, Bojan Polić, O. Barcot, D. Sapunar
OBJECTIVETo conduct scientometric studies on PhD ("Doctor of Philosophy") theses (i.e., doctoral theses), researchers should be able to access the theses. We aimed to explore how to obtain a list and full text of the defended PhD theses from medical schools in Croatia over 30 years (from the beginning of 1992 to the end of 2021).METHODSWe tried to obtain information from the Croatian Bureau of Statistics, the National and University Library in Zagreb (NSK), universities, medical schools and online repositories.RESULTSWe could not find a single list (source) of all PhD theses. Based on 4 different sources (website of the University of Zagreb and Medical School in Rijeka; school administrator from Split; library catalog from Osijek), we gathered information that from the beginning of 1992 to the end of 2021, there were 2955 PhD theses defended at medical schools in Croatia - 357 in Osijek, 550 in Rijeka, 337 in Split and 1711 in Zagreb. In May 2022, the online Croatian Digital Dissertations Repository contained 631 (22%) of full-text theses in Portable Document Format (PDF). University of Zagreb School of Medicine has its own repository that holds the full text of 834 (49%) of their PhD theses. One of the three PhD programs of the University of Split School of Medicine, namely Translational Research in Biomedicine (TRIBE), published full texts of all PhD theses defended at that program on its website. NSK held 2650 (90%) of the theses in a printed version.CONCLUSIONIt was extremely challenging to access the list and full texts of doctoral theses defended in Croatia. Making PhD theses publicly available would ensure transparency and enable analyses that should improve scientific policy.
目的要对博士学位论文(即博士论文)进行科学计量学研究,研究人员必须能够获得这些论文。我们试图从克罗地亚统计局、萨格勒布国家和大学图书馆 (NSK)、大学、医学院和在线资料库获取相关信息。根据 4 个不同来源(萨格勒布大学和里耶卡医学院网站;斯普利特的学校管理员;奥西耶克的图书馆目录),我们收集到以下信息:从 1992 年初到 2021 年底,克罗地亚医学院共有 2955 篇博士论文答辩,其中奥西耶克 357 篇,里耶卡 550 篇,斯普利特 337 篇,萨格勒布 1711 篇。2022年5月,在线克罗地亚数字论文库收录了631篇(22%)可移植文件格式(PDF)的论文全文。萨格勒布大学医学院拥有自己的论文库,其中包含 834 篇(49%)博士论文全文。斯普利特大学医学院的三个博士项目之一,即生物医学转化研究(TRIBE),在其网站上公布了该项目所有答辩博士论文的全文。NSK拥有2650篇(90%)论文的印刷版。公开博士论文将确保透明度,并有助于进行分析,从而改进科学政策。
{"title":"Difficulties in Accessing the List and Full Text of the Defended PhD Theses from Medical Schools: a Retrospective Case Study from Croatia.","authors":"Livia Puljak, Matea Tolić, Marko Sablić, Vlatko Silobrčić, Marija Heffer, Bojan Polić, O. Barcot, D. Sapunar","doi":"10.5644/ama2006-124.437","DOIUrl":"https://doi.org/10.5644/ama2006-124.437","url":null,"abstract":"OBJECTIVE\u0000To conduct scientometric studies on PhD (\"Doctor of Philosophy\") theses (i.e., doctoral theses), researchers should be able to access the theses. We aimed to explore how to obtain a list and full text of the defended PhD theses from medical schools in Croatia over 30 years (from the beginning of 1992 to the end of 2021).\u0000\u0000\u0000METHODS\u0000We tried to obtain information from the Croatian Bureau of Statistics, the National and University Library in Zagreb (NSK), universities, medical schools and online repositories.\u0000\u0000\u0000RESULTS\u0000We could not find a single list (source) of all PhD theses. Based on 4 different sources (website of the University of Zagreb and Medical School in Rijeka; school administrator from Split; library catalog from Osijek), we gathered information that from the beginning of 1992 to the end of 2021, there were 2955 PhD theses defended at medical schools in Croatia - 357 in Osijek, 550 in Rijeka, 337 in Split and 1711 in Zagreb. In May 2022, the online Croatian Digital Dissertations Repository contained 631 (22%) of full-text theses in Portable Document Format (PDF). University of Zagreb School of Medicine has its own repository that holds the full text of 834 (49%) of their PhD theses. One of the three PhD programs of the University of Split School of Medicine, namely Translational Research in Biomedicine (TRIBE), published full texts of all PhD theses defended at that program on its website. NSK held 2650 (90%) of the theses in a printed version.\u0000\u0000\u0000CONCLUSION\u0000It was extremely challenging to access the list and full texts of doctoral theses defended in Croatia. Making PhD theses publicly available would ensure transparency and enable analyses that should improve scientific policy.","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"21 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140722019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of a Unified Register of Donor Sexual Gametes in the Republic of Kazakhstan. 在哈萨克斯坦共和国建立性配子捐献者统一登记册。
Q3 Medicine Pub Date : 2024-04-08 DOI: 10.5644/ama2006-124.436
Leila Chalova, Vyacheslav Lokshin, Vladimir Kiyan, Botagoz Turdaliyeva, A. Kinzhibayev
OBJECTIVEThe purpose of this narrative review paper was to review the state and development of the field of donor gametes in Kazakhstan, compare its legislative and technical capabilities with other countries and identify key steps towards the establishment of a unified register of donor gametes in the Republic.MATERIALS AND METHODSThe narrative review paper conducted an analysis of scientific publications and legal documents to examine the implementation of Assisted Reproductive Technologies (ART), focusing on Donor Sexual Gametes (DSG), globally. It utilized medical publications from 2019 to 2023, legal acts, and recommendations from global health organizations to analyze eligibility criteria, legal regulations, and the social aspects of ART across different regions.RESULTSIn Kazakhstan, ART is regulated by legislation, with DSG procedures governed by age limits, medical screening, and restrictions on the number of children born from donated gametes. Worldwide, practices vary, but there is growing interest in establishing a unified register of reproductive donor material to enhance transparency and accountability. However, legal gaps and ethical considerations must be addressed.CONCLUSIONThe study identifies gaps in Kazakhstan's legislation compared to Western countries, emphasizing the necessity for enhanced legal rights for donors and recipients, including options for anonymity. Ethical concerns highlight the importance of confidentiality and data security in accessing the donor registry. Overall, implementing such a register promises to enhance transparency, safety, and accountability in reproductive medicine.
本文旨在回顾哈萨克斯坦捐献配子领域的现状和发展,将其立法和技术能力与其他国家进行比较,并确定在哈萨克斯坦共和国建立统一的捐献配子登记册的关键步骤。结果在哈萨克斯坦,辅助生殖技术受法律监管,性配子捐献程序受年龄限制、医疗筛查和捐献配子生育子女数量限制的制约。世界各地的做法各不相同,但人们对建立统一的生殖捐献者材料登记册以提高透明度和问责制的兴趣与日俱增。该研究发现了哈萨克斯坦立法与西方国家相比存在的差距,强调有必要加强捐献者和受捐者的法律权利,包括匿名选择。伦理方面的问题凸显了访问捐赠者登记册时保密和数据安全的重要性。总体而言,实施这样一个登记册有望提高生殖医学的透明度、安全性和问责制。
{"title":"Establishment of a Unified Register of Donor Sexual Gametes in the Republic of Kazakhstan.","authors":"Leila Chalova, Vyacheslav Lokshin, Vladimir Kiyan, Botagoz Turdaliyeva, A. Kinzhibayev","doi":"10.5644/ama2006-124.436","DOIUrl":"https://doi.org/10.5644/ama2006-124.436","url":null,"abstract":"OBJECTIVE\u0000The purpose of this narrative review paper was to review the state and development of the field of donor gametes in Kazakhstan, compare its legislative and technical capabilities with other countries and identify key steps towards the establishment of a unified register of donor gametes in the Republic.\u0000\u0000\u0000MATERIALS AND METHODS\u0000The narrative review paper conducted an analysis of scientific publications and legal documents to examine the implementation of Assisted Reproductive Technologies (ART), focusing on Donor Sexual Gametes (DSG), globally. It utilized medical publications from 2019 to 2023, legal acts, and recommendations from global health organizations to analyze eligibility criteria, legal regulations, and the social aspects of ART across different regions.\u0000\u0000\u0000RESULTS\u0000In Kazakhstan, ART is regulated by legislation, with DSG procedures governed by age limits, medical screening, and restrictions on the number of children born from donated gametes. Worldwide, practices vary, but there is growing interest in establishing a unified register of reproductive donor material to enhance transparency and accountability. However, legal gaps and ethical considerations must be addressed.\u0000\u0000\u0000CONCLUSION\u0000The study identifies gaps in Kazakhstan's legislation compared to Western countries, emphasizing the necessity for enhanced legal rights for donors and recipients, including options for anonymity. Ethical concerns highlight the importance of confidentiality and data security in accessing the donor registry. Overall, implementing such a register promises to enhance transparency, safety, and accountability in reproductive medicine.","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"250 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140730592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
George Sclavunos (1869-1954): Anatomical Insights and His Contribution into the "Magenstrasse of Waldeyer". 乔治-斯克拉夫诺斯(1869-1954 年):解剖学见解及其对 "瓦尔德耶尔的马根大街 "的贡献。
Q3 Medicine Pub Date : 2024-04-01 DOI: 10.5644/ama2006-124.433
Ioanna Verzoviti, Michail Saintanis, Dimosthenis Chrysikos, Dimitrios Filippou, Dimitrios Schizas, Ioannis K Antonopoulos, Theodore Troupis

The purpose of this article is to present a well-known physician and highlight his contribution into an essential, but neglected anatomical feature. George Sclavunos (1869-1954) was a 20th century Greek physician, whose scientific work was a significant milestone in global medical knowledge. In 1899 he became Professor of Anatomy and Head Director of the Department of Anatomy. In 1906 Sclavunos G. published the first volume of the three volume book "Human Anatomy" (1906-1926), which is characterized by its unparalleled illustrations. For more than a century it was the most important book of medical literature in Greece. In 1926 he became a Full Member of the Academy of Athens and was named Life Partner of the International Anatomical Society. His interests included Anatomy, Physiology, Histology, as well as Osteology and Syndesmology. In his book "Human Anatomy", he described for first time the "Sialine Groove of the Stomach", which was described by Waldeyer-Hartz almost at the same time as the "Magenstrasse", a German word that means "stomach road". It is a ribbon-like path that extends along the lesser curvature of the stomach from the gastric cardia to the antrum and releases the gastric content directly into the small intestine. Its importance is confirmed by its association not only with drug delivery, but also with anti-obesity surgical techniques. The old German term has come back into common medical usage in view of the commonly performed Magenstrasse and Mill procedure, a form of bariatric surgery. CONCLUSION: Sclavunos G. managed to observe an anatomical structure that has remained of great importance until today.

本文旨在介绍一位著名的医生,并强调他对一个重要但被忽视的解剖学特征所做的贡献。乔治-斯克拉夫诺斯(George Sclavunos,1869-1954 年)是 20 世纪的希腊医生,他的科研成果是全球医学知识的重要里程碑。1899 年,他成为解剖学教授和解剖学系主任。1906 年,斯克拉夫诺斯-G.出版了三卷本《人体解剖学》(1906-1926 年)的第一卷,其特点是插图无与伦比。一个多世纪以来,该书一直是希腊最重要的医学著作。1926 年,他成为雅典科学院正式院士,并被任命为国际解剖学会终身合伙人。他的研究领域包括解剖学、生理学、组织学以及骨骼学和综合病理学。他在《人体解剖学》一书中首次描述了 "胃的膳食纤维沟",瓦尔德耶-哈茨几乎在同一时间将其描述为 "Magenstrasse"(德语,意为 "胃路")。它是沿着胃小弯从胃贲门延伸到胃窦的一条带状路径,将胃内容物直接释放到小肠中。其重要性不仅体现在药物输送方面,还体现在抗肥胖外科技术方面。鉴于 Magenstrasse 和 Mill 手术是一种常见的减肥手术,这一古老的德语术语又重新成为医学界的常用术语。结论:Sclavunos G. 成功地观察到了一种解剖结构,这种结构直到今天仍具有重要意义。
{"title":"George Sclavunos (1869-1954): Anatomical Insights and His Contribution into the \"Magenstrasse of Waldeyer\".","authors":"Ioanna Verzoviti, Michail Saintanis, Dimosthenis Chrysikos, Dimitrios Filippou, Dimitrios Schizas, Ioannis K Antonopoulos, Theodore Troupis","doi":"10.5644/ama2006-124.433","DOIUrl":"10.5644/ama2006-124.433","url":null,"abstract":"<p><p>The purpose of this article is to present a well-known physician and highlight his contribution into an essential, but neglected anatomical feature. George Sclavunos (1869-1954) was a 20th century Greek physician, whose scientific work was a significant milestone in global medical knowledge. In 1899 he became Professor of Anatomy and Head Director of the Department of Anatomy. In 1906 Sclavunos G. published the first volume of the three volume book \"Human Anatomy\" (1906-1926), which is characterized by its unparalleled illustrations. For more than a century it was the most important book of medical literature in Greece. In 1926 he became a Full Member of the Academy of Athens and was named Life Partner of the International Anatomical Society. His interests included Anatomy, Physiology, Histology, as well as Osteology and Syndesmology. In his book \"Human Anatomy\", he described for first time the \"Sialine Groove of the Stomach\", which was described by Waldeyer-Hartz almost at the same time as the \"Magenstrasse\", a German word that means \"stomach road\". It is a ribbon-like path that extends along the lesser curvature of the stomach from the gastric cardia to the antrum and releases the gastric content directly into the small intestine. Its importance is confirmed by its association not only with drug delivery, but also with anti-obesity surgical techniques. The old German term has come back into common medical usage in view of the commonly performed Magenstrasse and Mill procedure, a form of bariatric surgery. CONCLUSION: Sclavunos G. managed to observe an anatomical structure that has remained of great importance until today.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":" ","pages":"106-113"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica academica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1